$336.50 0.5%
CI Stock Price vs. AI Score
Data gathered: November 28

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Cigna (CI)

Analysis generated May 2, 2024. Powered by Chat GPT.

Cigna Corporation is a global health service organization dedicated to improving the health, well-being, and peace of mind of those it serves. With its vast array of health services, including medical, dental, disability, life, and accident insurance products, the company caters to individuals, employers, and government entities, among others. With its recent expansion and strategic initiatives, Cigna has positioned itself as a leader in the healthcare industry. The company emphasizes value-driven healthcare and innovative solutions to ensure accessibility and affordability for its clients.

Read full AI stock Analysis

Stock Alerts - Cigna (CI)

company logo Cigna | November 27
Job postings are down by 16.6% in the last couple of days.
company logo Cigna | November 12
Ro Khanna (member of U.S. congress) is buying shares
company logo Cigna | November 11
Price is up by 7.9% in the last 24h.
company logo Cigna | November 8
App downloads are down by 11.4% in the last couple of days.

About Cigna

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.


Cigna
Price $336.50
Target Price Sign up
Volume 1,770,000
Market Cap $93.2B
Year Range $308.23 - $366.85
Dividend Yield 1.67%
PE Ratio 31.75
Analyst Rating 86% buy
Industry Insurance

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2463.7B70.6B-6.95B739M1.92B7.510
Q2 '2460.5B67.6B-7.1B1.55B2.71B6.720
Q1 '2457.3B64.4B-7.18B-277M806M6.470
Q4 '2351.1B252M-252M-504M-575M6.790
Q3 '2349B55.7B-6.69B1.41B2.61B6.770

Insider Transactions View All

DeLaney William J III filed to sell 17,539 shares at $342.7.
August 21 '24
Triplett Michael W filed to sell 37,867 shares at $331.
August 14 '24
Triplett Michael W filed to sell 32,833 shares at $329.6.
August 14 '24
Jones Nicole S filed to sell 24,587 shares at $331.
August 14 '24
Evanko Brian C filed to sell 39,923 shares at $345.
June 26 '24

What is the Market Cap of Cigna?

The Market Cap of Cigna is $93.2B.

What is Cigna's PE Ratio?

As of today, Cigna's PE (Price to Earnings) ratio is 31.75.

What is the current stock price of Cigna?

Currently, the price of one share of Cigna stock is $336.50.

How can I analyze the CI stock price chart for investment decisions?

The CI stock price chart above provides a comprehensive visual representation of Cigna's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cigna shares. Our platform offers an up-to-date CI stock price chart, along with technical data analysis and alternative data insights.

Does CI offer dividends to its shareholders?

Yes, Cigna (CI) offers dividends to its shareholders, with a dividend yield of 1.67%. This dividend yield represents Cigna's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Cigna in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Cigna?

Some of the similar stocks of Cigna are Allstate, Progressive, MetLife, Aflac, and Lemonade.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.